Alumis to Participate in Upcoming February Investor Conferences
Alumis Inc. (ALMS)
Company Research
Source: GlobeNewswire
SOUTH SAN FRANCISCO, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Alumis Inc. (Nasdaq: ALMS), a late-stage biopharma company developing next-generation targeted therapies for patients with immune-mediated diseases, today announced that the Company will participate in the following investor conferences: Guggenheim Emerging Outlook: Biotech Summit 2026February 11-12, 2026, New York, NYFireside chat: Thursday, February 12, 2026 at 9:00 am ET Oppenheimer 36th Annual Healthcare Life Sciences ConferenceFebruary 25-26, 2026, VirtualPresentation: Thursday, February 26, 2026 at 3:20 pm ET To access the live webcasts please visit the “Events” page of the “Investors" section of the Alumis website. Webcast replays will be archived on the company's website for 90 days. About Alumis Alumis is a late-stage biopharma company developing next-generation targeted therapies with the potential to significantly improve patient health and outcomes across a range of immune-mediated diseases. Leveraging it
Show less
Read more
Impact Snapshot
Event Time:
ALMS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ALMS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ALMS alerts
High impacting Alumis Inc. news events
Weekly update
A roundup of the hottest topics
ALMS
News
- Alumis (NASDAQ:ALMS) was upgraded by analysts at Chardan Capital to a "strong-buy" rating.MarketBeat
- Alumis (NASDAQ:ALMS) was given a new $37.00 price target on by analysts at Loop Capital.MarketBeat
- Alumis (NASDAQ:ALMS) is now covered by analysts at Chardan Capital. They set a "buy" rating on the stock.MarketBeat
- Alumis (NASDAQ:ALMS) was given a new $37.00 price target on by analysts at Chardan Capital.MarketBeat
- HC Wainwright & Co. Hikes Alumis Inc. (ALMS)'s Price Target To $40 From $20, Reiterates Buy Rating [Yahoo! Finance]Yahoo! Finance
ALMS
Sec Filings
- 1/30/26 - Form S-8
- 1/28/26 - Form 4
- 1/28/26 - Form 4
- ALMS's page on the SEC website